- Home
- AUPH vs ERII Comparison
AUPH vs ERII Comparison
Compare AUPH & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- ERII
- Stock Information
- Founded
- AUPH 1993
- ERII 1992
- Country
- AUPH Canada
- ERII United States
- Employees
- AUPH N/A
- ERII N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- ERII Industrial Machinery/Components
- Sector
- AUPH Health Care
- ERII Technology
- Exchange
- AUPH Nasdaq
- ERII Nasdaq
- Market Cap
- AUPH 1.3B
- ERII 851.0M
- IPO Year
- AUPH 1999
- ERII 2008
- Fundamental
- Price
- AUPH $8.77
- ERII $14.89
- Analyst Decision
- AUPH Strong Buy
- ERII Strong Buy
- Analyst Count
- AUPH 3
- ERII 4
- Target Price
- AUPH $10.33
- ERII $20.75
- AVG Volume (30 Days)
- AUPH 1.3M
- ERII 370.7K
- Earning Date
- AUPH 02-13-2025
- ERII 02-19-2025
- Dividend Yield
- AUPH N/A
- ERII N/A
- EPS Growth
- AUPH N/A
- ERII 22.95
- EPS
- AUPH N/A
- ERII 0.33
- Revenue
- AUPH $220,361,000.00
- ERII $135,062,000.00
- Revenue This Year
- AUPH $36.97
- ERII $15.74
- Revenue Next Year
- AUPH $16.43
- ERII $12.00
- P/E Ratio
- AUPH N/A
- ERII $44.91
- Revenue Growth
- AUPH 38.72
- ERII 19.05
- 52 Week Low
- AUPH $4.71
- ERII $12.26
- 52 Week High
- AUPH $10.67
- ERII $20.27
- Technical
- Relative Strength Index (RSI)
- AUPH 45.91
- ERII 38.52
- Support Level
- AUPH $8.89
- ERII $14.50
- Resistance Level
- AUPH $9.31
- ERII $15.27
- Average True Range (ATR)
- AUPH 0.34
- ERII 0.59
- MACD
- AUPH -0.11
- ERII -0.04
- Stochastic Oscillator
- AUPH 1.43
- ERII 13.54
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.